Related references
Note: Only part of the references are listed.Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer
J. Dorn et al.
ANNALS OF ONCOLOGY (2011)
Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas
Jane Bayani et al.
MOLECULAR ONCOLOGY (2011)
Clinical Significance of Human Kallikrein7 Gene Expression in Colorectal Cancer
Yasuhiro Inoue et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
Peter Goettig et al.
BIOCHIMIE (2010)
Interdependence of kallikrein-related peptidases in proteolytic networks
Nathalie Beaufort et al.
BIOLOGICAL CHEMISTRY (2010)
Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs
Nicole M. White et al.
BIOLOGICAL CHEMISTRY (2010)
Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells
M. Murohashi et al.
BRITISH JOURNAL OF CANCER (2010)
Association of TMPRSS2 and KLK11 gene expression levels with clinical progression of human prostate cancer
Xuecheng Bi et al.
MEDICAL ONCOLOGY (2010)
IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis
Dawei Li et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
M. Talieri et al.
BRITISH JOURNAL OF CANCER (2009)
Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma
Chang Do Jee et al.
EUROPEAN JOURNAL OF CANCER (2009)
Functional Roles of Human Kallikrein-related Peptidases
Georgia Sotiropoulou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Gastric cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
D. Cunningham et al.
ANNALS OF ONCOLOGY (2008)
Gene-expression profiling in Chinese patients with colon cancer by coupling experimental and bioinformatic genomewide gene-expression analyses - Identification and validation of IFITM3 as a biomarker of early colon carcinogenesis
Junwei Fan et al.
CANCER (2008)
Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples
Yasuhide Yamada et al.
CANCER SCIENCE (2008)
A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma
Chris Planque et al.
CLINICAL CANCER RESEARCH (2008)
Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression
Carey K. Anders et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Screening for gastric cancer in Asia: current evidence and practice
Wai K. Leung et al.
LANCET ONCOLOGY (2008)
Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis
Hyesook Yoon et al.
PROTEIN SCIENCE (2008)
Intracellular signaling pathways regulate hormone-dependent kallikrein gene expression
Miltiadis Paliouras et al.
TUMOR BIOLOGY (2008)
Human tissue kallikreins: The cancer biomarker family
Miltiadis Paliouras et al.
CANCER LETTERS (2007)
Identification of genes with correlated patterns of variations in DNA copy number and gene expression level in gastric cancer
Sanghwa Yang et al.
GENOMICS (2007)
KCNE2, a down-regulated gene identified by in silico analysis, suppressed proliferation of gastric cancer cells
Pan Yanglin et al.
CANCER LETTERS (2007)
In silico identification and Bayesian phylogenetic analysis of multiple new mammalian kallikrein gene families
Marc B. Elliott et al.
GENOMICS (2006)
Multiple promoters regulate tissue-specific alternative splicing of the human kallikrein gene, KLK11/hippostasin
Shinichi Mitsui et al.
FEBS JOURNAL (2006)
Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues
Chris Planque et al.
BIOLOGICAL CHEMISTRY (2006)
mRNA expression analysis of human kallikrein 11 (KLK11) may be useful in the discrimination of benign prostatic hyperplasia from prostate cancer after needle prostate biopsy
A Scorilas et al.
BIOLOGICAL CHEMISTRY (2006)
Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma
CD Petraki et al.
TUMOR BIOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer
P Stavropoulou et al.
CLINICA CHIMICA ACTA (2005)
Human tissue kallikrein gene family: applications in cancer
CV Obiezu et al.
CANCER LETTERS (2005)
Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling
CB Gilks et al.
GYNECOLOGIC ONCOLOGY (2005)
Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas - Role in epithelio-stromal interactions and matrix metalloproteinase induction
EE Gabison et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer
K Shigemasa et al.
CLINICAL CANCER RESEARCH (2004)
The emerging roles of human tissue kallikreins in cancer
CA Borgoño et al.
NATURE REVIEWS CANCER (2004)
Favorable prognostic value of tissue human kallikrein 11 (hk11) in patients with ovarian carcinoma
CA Borgoño et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Share Paper
